|Bid||108.16 x 1100|
|Ask||108.19 x 1300|
|Day's Range||104.85 - 108.57|
|52 Week Range||83.14 - 151.86|
|Beta (5Y Monthly)||1.08|
|PE Ratio (TTM)||42.56|
|Earnings Date||Feb 07, 2023 - Feb 13, 2023|
|Forward Dividend & Yield||3.24 (3.03%)|
|Ex-Dividend Date||Sep 22, 2022|
|1y Target Est||118.57|
Subscribe to Yahoo Finance Plus to view Fair Value for IFF
NEW YORK, December 07, 2022--IFF (NYSE: IFF) today announced that Nicolas Mirzayantz, president of IFF’s Nourish division, will leave the Company following a successful 34+ year tenure, effective Dec. 31, 2022. Upon his departure, IFF CEO Frank Clyburn will lead IFF’s current Nourish division until a replacement is named.
NEW YORK, December 07, 2022--IFF (NYSE: IFF) today announced the next phase of its strategic transformation by previewing its refreshed strategic plan and new operating model, developed through an extensive assessment with the Company’s senior leadership, customers, investors and key partners.
IFF (NYSE: IFF) has unveiled research in partnership with the Universidad Católica San Antonio de Murcia (UCAM), demonstrating that the AB-Fortis® iron ingredient is significantly better tolerated than a common iron salt. AB-Fortis® is an iron salt encapsulated in alginate—a natural seaweed-derived polysaccharide—making the ingredient appropriate for vegetarians and vegans. This unique encapsulation technology is particularly robust under high pressure and temperature during processing. AB-Forti